Inventiva has announced the appointment of Chris Benecchi as Chief Operating Officer. Mr. Benecchi will lead the company's operational readiness as it approaches pivotal study results for its treatment of MASH, with a potential U.S
Company Information
Company
Inventiva
Location
50 Rue de Dijon
Daix, Bourgogne-Franche-Comté, France
About
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.
Don't miss Inventiva's next move
Get an email the moment Inventiva changes its leadership, hires an exec, or expands, usually minutes after it happens.